Strategic Initiative

Slingshot members are tracking this corporate initiative:

AstraZeneca (AZN) receives US clearance of proposed acquisition of Alexion (ALXN)

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
AZN Community voting in process
ALXN Community voting in process

Additional Information

Additional Relevant Details
 AstraZeneca’s proposed acquisition of Alexion Pharmaceuticals, Inc (Alexion) has achieved an important step toward completion, having cleared US Federal Trade Commission review. This follows the conclusion of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.
The announcement follows competition clearances in Canada, Brazil, Russia and other countries globally, with a full list available on Additional global regulatory clearances are pending, including but not limited to the UK, EU and Japan.
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Apr 16, 2021
Projected Implementation:
Q2, 2021
Relevance Tracked Until:
Q3, 2021
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Immunology